News Sentiment

CCXI sentiment intelligence

Churchill Capital Corp XI news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 25 relevant articles
Exchange NASDAQ United States
Sector Financial Services Market context
Industry Shell Companies Read-through group
Latest close 15.55 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

74/100 classification confidence.

Company focus 24

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-18.6% over one week, +52.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Hon Hai subsidiary acquires stake in Churchill Capital XI By Investing.com

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 74/100 classification
One-week reaction -18.6% Price reacting lower
Trend fit Trend inactive 52.2% over four weeks
Fair value -56.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 20
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 24
Industry context 0
Sector context 1

Sources

Coverage mix

Publishers
TradingView 4
Market source 3
Stock Titan 3
Seeking Alpha 2
Benzinga 2
Investing.com Canada 1
Business Wire 1
Moomoo 1

Event Lens

What the news is about

Classified themes
Deals and strategy 9
Market update 9
Earnings 3
Balance sheet 2
Macro sensitivity 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-25 of 25
TradingView Direct company coverage

Long term debt to total equity ratio of ChemoCentryx Inc. – NASDAQ:CCXI

This page displays information about the long-term debt to total equity ratio of ChemoCentryx Inc. (NASDAQ: CCXI). The content presented includes a period value, change, and percentage change for this financial metric. The data is sourced from ICE Data Services and FactSet Resear

Tone
Neutral 50/100
Event
Balance sheet
Published
22 Mar 2026 16:39
Source
TradingView
TradingView Direct company coverage

Book value per share of ChemoCentryx Inc. – NASDAQ:CCXI

This article briefly presents the book value per share for ChemoCentryx Inc. (NASDAQ: CCXI). The content appears to be a stub or a section within a financial data platform, providing a heading for financial figures without the actual data being visible in the provided text.

Tone
Neutral 50/100
Event
Market update
Published
22 Mar 2026 09:39
Source
TradingView
TradingView Direct company coverage

Cash per share of ChemoCentryx Inc. – NASDAQ:CCXI

This article provides financial data for ChemoCentryx Inc. (NASDAQ: CCXI), specifically focusing on its cash per share value. It highlights the company's stock market listing on Nasdaq and presents an overview of financial indicators. The content is concise, indicating a closed m

Tone
Neutral 50/100
Event
Balance sheet
Published
21 Mar 2026 21:10
Source
TradingView
GlobeNewswire Sector context

ChemoCentryx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights

ChemoCentryx announced its financial results for Q4 and full year 2021, reporting total revenue of $32.2 million for 2021. The company highlighted the US approval and launch of TAVNEOS for ANCA-associated vasculitis, generating $1.0 million in net product sales in Q4 2021, and it

Tone
Positive 74/100
Event
Earnings
Published
01 Mar 2022 02:38
Source
GlobeNewswire
TMX Newsfile Direct company coverage

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of ChemoCentryx, Inc

Rigrodsky Law, P.A. has announced an investigation into ChemoCentryx, Inc. (NASDAQ: CCXI) on behalf of stockholders. The investigation follows a class action complaint alleging that ChemoCentryx executives misrepresented and/or failed to disclose critical information regarding th

Tone
Neutral 50/100
Event
Regulatory and legal
Published
04 Feb 2022 11:33
Source
TMX Newsfile